Open

Type 2 Diabetes + High Blood Pressure + Cardiovascular Disease Study

A study to test vicadrostat taken together with empagliflozin in people with type 2 diabetes, high blood pressure, and cardiovascular disease.

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)

Location

North Carolina (Statewide)

What will be asked of you

At each visit, you will meet with a member of the study team and answer questions about your health. The study also involves blood draws, ECGs, and willingness to take the study medication regularly.

Incentives

Information provided upon request, study medication, study results

In-person visits:
6 in the first year and then approximately 2 visits per year until the study is over

Phone or online visits:
3 in the first year and then approximately 2 phone visits per year until the study is over

Total length of participation:
Approximately 30 to 51 months

Looking for Specific Volunteers

Able to participate:

you have hypertension and are taking medication for it
you have type 2 diabetes and are taking medication for it
you have cardiovascular disease (coronary artery disease, peripheral artery disease, or cerebrovascular disease) and are taking medication for it

Not eligible if:

you have history of heart failure
you take restricted medications and are unwilling to discontinue them (more information provided upon request)
you are of childbearing potential and unwilling to use highly effective methods of birth control

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

UNC Eastowne Medical Office Building
100 Eastowne Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Klara Klein
Medicine-Endocrinology

Study Type

Clinical or Medical
Interventional

Study Topics

Diabetes
Heart and Circulation

IRB Number

25-1748

ClinicalTrials.gov

NCT07064473

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.